Crizalk 250 mg capsule is used in the treatment of non-small cell lung cancer
How it works
Crizalk 250 mg capsule In patients with cancer, a change in DNA (genetic material) triggers a signal which produces abnormal cancer cells. Crizalk 250 mg capsule blocks this signal, and thus stops the production of these cancer cells.
Common side effects
Neuropathy, Decreased white blood cell count (neutrophils), Anemia, Bradycardia, Constipation, Diarrhoea, Dizziness, Bitter taste, Edema, Fainting, Fatigue, Liver toxicity, Decreased potassium level in blood, Indigestion, Loss of appetite, Nausea, Rash, Renal cyst, Vision disorder, Vomiting, Decreased white blood cell count